Tacrolimus cream + Clobetasol cream
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vulvar Lichen Sclerosus
Conditions
Vulvar Lichen Sclerosus
Trial Timeline
Apr 1, 2006 → Jan 1, 2010
NCT ID
NCT00757874About Tacrolimus cream + Clobetasol cream
Tacrolimus cream + Clobetasol cream is a phase 2 stage product being developed by Astellas Pharma for Vulvar Lichen Sclerosus. The current trial status is completed. This product is registered under clinical trial identifier NCT00757874. Target conditions include Vulvar Lichen Sclerosus.
What happened to similar drugs?
0 of 2 similar drugs in Vulvar Lichen Sclerosus were approved
Approved (0) Terminated (1) Active (1)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00757874 | Phase 2 | Completed |
Competing Products
7 competing products in Vulvar Lichen Sclerosus
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Estradiol | Sun Pharmaceutical | Phase 3 | 32 |
| Estradiol Vaginal Tablets 10 mcg (Glenmark) + Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk) + Placebo of Estradiol Vaginal Tablets 10 mcg (Glenmark) | Glenmark Pharmaceuticals | Phase 3 | 40 |
| Cisplatin + Pembrolizumab | Merck | Phase 2 | 39 |
| Cardunolizumab | Innovent Biologics | Phase 2 | 42 |
| AK104 + AK104+ Paclitaxel+Cisplatin or Carboplatin | Akeso | Phase 2 | 42 |
| AVA6103 | Avacta Group | Phase 1 | 26 |
| VGX-3100 + Imiquimod 5% Cream | Inovio Pharmaceuticals | Phase 2 | 25 |